Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
| dc.contributor.author | Tasci, Elif Seno | |
| dc.contributor.author | Oyan, Basak | |
| dc.contributor.author | Sonmez, Ozlem | |
| dc.contributor.author | Mutlu, Arda Ulas | |
| dc.contributor.author | Atci, Muhammed Mustafa | |
| dc.contributor.author | Sakin, Abdullah | |
| dc.contributor.author | Oner, Irem | |
| dc.contributor.author | Cinkir, Havva Yesil | |
| dc.contributor.author | Eryilmaz, Melek Karakurt | |
| dc.contributor.author | Caglayan, Dilek | |
| dc.contributor.author | Balcik, Onur Yazdan | |
| dc.contributor.author | Paksoy, Nail | |
| dc.contributor.author | Karabulut, Senem | |
| dc.contributor.author | Salim, Derya Kivrak | |
| dc.contributor.author | Bilir, Cemil | |
| dc.contributor.author | Ozen, Mirac | |
| dc.contributor.author | Ozcelik, Melike | |
| dc.contributor.author | Arican, Ali | |
| dc.contributor.author | Akagunduez, Baran | |
| dc.contributor.author | Inal, Ali | |
| dc.contributor.author | Aydin, Dincer | |
| dc.contributor.author | Ozer, Leyla | |
| dc.contributor.author | Gulmez, Ahmet | |
| dc.contributor.author | Turhal, Nazim Serdar | |
| dc.contributor.author | Esen, Selin Aktuerk | |
| dc.contributor.author | Algin, Efnan | |
| dc.contributor.author | Akbas, Sinem | |
| dc.contributor.author | Iriagac, Yakup | |
| dc.contributor.author | Sakalar, Teoman | |
| dc.contributor.author | Unal, Caglar | |
| dc.contributor.author | Er, Ozlem | |
| dc.contributor.author | Secmeler, Saban | |
| dc.contributor.author | Bozkurt, Mustafa | |
| dc.date.accessioned | 2025-10-16T15:13:51Z | |
| dc.date.issued | 2024 | |
| dc.identifier.doi | 10.1186/s12885-023-11783-5 | |
| dc.identifier.other | WOS:001135401800028 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/5970 | |
| dc.publisher | BMC | |
| dc.source | BMC CANCER | |
| dc.subject | Colon cancer | |
| dc.subject | Fluouracil | |
| dc.subject | Rechallenge | |
| dc.subject | Regorafenib | |
| dc.subject | Survival | |
| dc.subject | Third\\-line treatment | |
| dc.title | Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer | |
| dc.type | Article |
